GA
PROF
Gagnon Advisors’s Profound Medical PROF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Hold |
896,671
| – | – | 3.56% | 13 |
|
|
2025
Q1 | $5.22M | Hold |
896,671
| – | – | 3.68% | 14 |
|
|
2024
Q4 | $6.73M | Buy |
896,671
+149,445
| +20% | +$1.12M | 4.31% | 10 |
|
|
2024
Q3 | $5.95M | Hold |
747,226
| – | – | 3.84% | 10 |
|
|
2024
Q2 | $6.27M | Hold |
747,226
| – | – | 4.77% | 7 |
|
|
2024
Q1 | $6.37M | Buy |
747,226
+67,930
| +10% | +$579K | 5.53% | 7 |
|
|
2023
Q4 | $5.77M | Hold |
679,296
| – | – | 5.04% | 8 |
|
|
2023
Q3 | $6.93M | Hold |
679,296
| – | – | 5.8% | 5 |
|
|
2023
Q2 | $8.84M | Buy |
679,296
+30,831
| +5% | +$401K | 5.91% | 6 |
|
|
2023
Q1 | $6.02M | Hold |
648,465
| – | – | 4.04% | 13 |
|
|
2022
Q4 | $7.06M | Hold |
648,465
| – | – | 4.77% | 9 |
|
|
2022
Q3 | $2.62M | Buy |
648,465
+207,409
| +47% | +$838K | 1.7% | 23 |
|
|
2022
Q2 | $3.22M | Hold |
441,056
| – | – | 1.95% | 21 |
|
|
2022
Q1 | $3.97M | Buy |
441,056
+38,879
| +10% | +$350K | 1.83% | 23 |
|
|
2021
Q4 | $4.52M | Hold |
402,177
| – | – | 1.79% | 23 |
|
|
2021
Q3 | $5.89M | Buy |
402,177
+124,925
| +45% | +$1.83M | 2.34% | 21 |
|
|
2021
Q2 | $4.54M | Hold |
277,252
| – | – | 1.72% | 24 |
|
|
2021
Q1 | $5.58M | Hold |
277,252
| – | – | 2.3% | 21 |
|
|
2020
Q4 | $5.7M | Hold |
277,252
| – | – | 2.56% | 17 |
|
|
2020
Q3 | $4.89M | Buy |
277,252
+20,439
| +8% | +$361K | 3% | 15 |
|
|
2020
Q2 | $4.35M | Hold |
256,813
| – | – | 3.13% | 16 |
|
|
2020
Q1 | $2.5M | Buy |
+256,813
| New | +$2.5M | 2.33% | 18 |
|